Trial · NCT01914757
Adverse events345
Each adverse event the trial posted, group by group: the participants affected out of those at risk.
1 to 20 of 345
Download this page as JSON| Type | Event | Organ system | Group | Affected | At risk | Events |
|---|---|---|---|---|---|---|
| other | Pyrexia | General disorders | Benralizumab 30 mg q.4 Weeks | 16 | 438 | 20 |
| other | Pyrexia | General disorders | Benralizumab 30 mg q.8 Weeks | 13 | 428 | 13 |
| other | Pyrexia | General disorders | Placebo | 6 | 440 | 6 |
| other | Acute sinusitis | Infections and infestations | Benralizumab 30 mg q.4 Weeks | 6 | 438 | 6 |
| other | Acute sinusitis | Infections and infestations | Benralizumab 30 mg q.8 Weeks | 5 | 428 | 6 |
| other | Acute sinusitis | Infections and infestations | Placebo | 14 | 440 | 19 |
| other | Bronchitis | Infections and infestations | Benralizumab 30 mg q.4 Weeks | 40 | 438 | 51 |
| other | Bronchitis | Infections and infestations | Benralizumab 30 mg q.8 Weeks | 45 | 428 | 54 |
| other | Bronchitis | Infections and infestations | Placebo | 54 | 440 | 72 |
| other | Influenza | Infections and infestations | Benralizumab 30 mg q.4 Weeks | 24 | 438 | 27 |
| other | Influenza | Infections and infestations | Benralizumab 30 mg q.8 Weeks | 12 | 428 | 17 |
| other | Influenza | Infections and infestations | Placebo | 25 | 440 | 27 |
| other | Nasopharyngitis | Infections and infestations | Benralizumab 30 mg q.4 Weeks | 90 | 438 | 132 |
| other | Nasopharyngitis | Infections and infestations | Benralizumab 30 mg q.8 Weeks | 82 | 428 | 131 |
| other | Nasopharyngitis | Infections and infestations | Placebo | 92 | 440 | 147 |
| other | Pharyngitis | Infections and infestations | Benralizumab 30 mg q.4 Weeks | 17 | 438 | 21 |
| other | Pharyngitis | Infections and infestations | Benralizumab 30 mg q.8 Weeks | 10 | 428 | 10 |
| other | Pharyngitis | Infections and infestations | Placebo | 8 | 440 | 9 |
| other | Rhinitis | Infections and infestations | Benralizumab 30 mg q.4 Weeks | 12 | 438 | 13 |
| other | Rhinitis | Infections and infestations | Benralizumab 30 mg q.8 Weeks | 18 | 428 | 24 |
Source ClinicalTrials.govtrials-2026-11-12-0.5.0
Sources 3
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNo license stated
- NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
- NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/trials/v1/NCT01914757/events